American Century Companies’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
KL
O
SCM
NCM
KLC
American Century Companies's NPCE Position: Q1 2023 in Review
American Century Companies sold out of Neuropace (NPCE) in Q1 2023, closing a stake of 72,508 shares — an estimated $108K sold.
American Century Companies first reported a position in NPCE in Q2 2021 and held it in 7 quarters. The position peaked at $9.58M in Q2 2021. 24 funds tracked by Wall St. Rank hold NPCE as of Q1 2023.
- American Century Companies reported no remaining Neuropace position as of Q1 2023 after selling out during the quarter.
- American Century Companies sold 72,508 Neuropace shares in Q1 2023, an estimated $108K.
- American Century Companies first reported a position in Neuropace in Q2 2021 and held it in 7 quarters.
- American Century Companies's Neuropace position peaked at $9.58M in Q2 2021.
- 24 funds tracked by Wall St. Rank held Neuropace as of Q1 2023.
Based on American Century Companies's 13F filing for Q1 2023, filed 11 May 2023.